LCM Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by LCM Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by LCM Capital Management from 13F filings

Historical chart of LCM Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by LCM Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by LCM Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $377k 926 406.89
2023-09-30 $316k 910 347.74
2023-06-30 $281k 797 351.91
2023-03-31 $239k 758 315.07

More positions owned by LCM Capital Management

Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Msci Eafe Etf (EFA)
Vanguard World Fds Financials Etf (VFH)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Lockheed Martin Corporation (LMT)
Johnson & Johnson (JNJ)
Adobe Systems Incorporated (ADBE)
Wal-Mart Stores (WMT)

View all positions for LCM Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated